Ketamine vs. Antidepressants: What Every Patient Should Know

Medically reviewed by Dr. Ben Soffer, DO

Dr. Ben Soffer is a board-certified physician licensed in Florida and New Jersey. He personally evaluates and treats every Discreet Ketamine patient, and he wrote and reviewed this comparison.

Depression treatment draws on two very different toolkits. The first, and still the standard first step, is the antidepressant family: SSRIs like Zoloft, Prozac, and Lexapro, and SNRIs like Cymbalta and Effexor. These are daily pills that adjust serotonin and norepinephrine signaling over several weeks. The second is ketamine, an older anesthetic that, at low doses, produces a rapid antidepressant effect through an entirely different brain system. The first controlled evidence that ketamine could lift depression quickly was published in 2000 (Berman, 2000), and a landmark randomized trial in treatment-resistant patients followed in 2006 (Zarate, 2006).

Not everyone needs ketamine. For a first episode of depression, or for someone who has never tried medication, an SSRI is the sensible, well-studied starting point. Ketamine enters the conversation for treatment-resistant depression, which clinicians define as depression that has not responded to two or more adequate antidepressant trials, each at a therapeutic dose for roughly six to eight weeks. It is also worth considering when symptoms are severe enough that waiting six weeks to learn whether the next pill helps is not safe.

Cost belongs in an honest comparison. Generic SSRIs and SNRIs are inexpensive, often a few dollars a month with insurance. Ketamine varies widely by route: in-clinic IV infusion series are commonly reported in the several-hundred-dollars-per-session range, FDA-approved esketamine nasal spray (Spravato) is a higher-cost prescription treatment given only in a certified office (FDA, 2019), and supervised at-home oral ketamine programs generally sit below infusion pricing. The sections below compare the two approaches on mechanism, speed, response rates, and side effects.

Mechanisms of Action

The two drug classes reach mood through different doors. SSRIs raise serotonin in the synapse, and over several weeks the brain gradually adapts to that higher availability. That slow adaptation is why they take a month or more to do much of anything, and it is also why they have such a long, well-established track record for depression and anxiety. SNRIs do the same for serotonin and add norepinephrine on top. I tend to reach for them when an SSRI alone has left a patient only half-treated, since the extra target can cover a broader range of symptoms.

Ketamine works nothing like that. It started life as an anesthetic, and the full mechanism still is not mapped, but the short version is that it acts on glutamate receptors to drive a fast round of synaptic plasticity. New connections, quickly. That is why relief tends to arrive in hours to days rather than weeks. I go into the biology in more detail in how ketamine works.

Efficacy

For someone who has never been treated, a first SSRI is a reasonable bet, and plenty of people do well on one. The honest caveat is that the first agent often is not the one that works. Response varies from patient to patient, and it is common to try a second or third SSRI, or move to an SNRI, before landing on a good fit. That trial and error is the frustrating part of standard treatment, not a sign that the drugs are weak.

Where ketamine separates itself is treatment-resistant depression, meaning depression that has already shrugged off adequate antidepressant trials. In that population the meta-analytic response rate sits in the 60 to 75 percent range, and it lands within 24 to 72 hours rather than over weeks; the two-site randomized trial by Murrough and colleagues is one of the clearest demonstrations of that rapid effect (Murrough, 2013). For a patient in acute distress, that speed is not a luxury. A systematic review and meta-analysis found that a single dose of intravenous ketamine reduced suicidal ideation within a day (Wilkinson, 2018). I wrote separately about why ketamine works after two or more antidepressants have failed.

In my clinic, patients often describe that shift in their own words:

"Ketamine is helping me confront and address previously buried and inaccessible layers of deep pain and rage and sadness in a safe environment over time. Dr. Ben's expertise and own personal experience has been an invaluable resource on my ongoing journey to live with less suffering."

Moshe, verified patient (Google review)

Administration and Treatment Considerations

An SSRI or SNRI is a pill taken every day, usually for months or years, on an outpatient basis with no supervision required. That simplicity is a genuine advantage. The trade-off shows up in the remission math: on a single SSRI trial, full remission runs closer to 10 to 20 percent in treatment-resistant patients, so many people cycle through several agents before one holds.

Ketamine is delivered as IV infusions, nasal spray, or oral tablets and lozenges, always under clinical supervision. Most patients need maintenance dosing to keep the benefit, so it is not a one-and-done. On a complete induction course, roughly 30 to 50 percent of treatment-resistant patients reach full remission. Its speed is what makes it valuable when someone cannot safely wait six weeks to learn whether the next pill will help.

The two approaches are not mutually exclusive. For a patient who gets partial relief from a daily antidepressant, adding ketamine on top can deepen the response rather than replace the pill. A randomized trial found that esketamine added to an oral antidepressant improved symptoms in treatment-resistant depression (Daly, 2018).

Side Effects and Safety

The two profiles differ mostly in timing. Most people tolerate SSRIs and SNRIs well, and when side effects appear they are usually mild. The catch is that the ones that do occur, such as sexual dysfunction, weight gain, and withdrawal-like symptoms if the drug is stopped, tend to persist for as long as the medication is taken.

Ketamine's side effects are more noticeable in the moment and much shorter in duration. During a session a patient may feel dissociation, mild nausea, a temporary rise in blood pressure, and sometimes brief hallucinatory imagery, and these typically resolve within hours. Two honest caveats sit alongside that: long-term safety data is still limited, and ketamine carries some abuse potential. Both are reasons the treatment belongs under supervision, and both are why misuse stays unlikely inside a proper safety protocol.

Supervision is the part patients tend to notice most. One described the ongoing check-ins this way:

"Have to give Dr. Ben Soffer an A+. He's a very caring individual who is focused on me and my well being as a patient when we meet via the internet. Very professional and good with communicating about how I'm doing, side effects if they should occur. He wants me to be careful and not fall, and cares about a positive benefit for me."

Jack Webb, verified patient (Google review)

Patient Considerations

There is no universal answer here, and the decision comes down to a handful of specifics I walk through with each patient. How severe are the symptoms. What has already been tried and failed. How much side-effect burden someone can live with. Whether rapid relief is a clinical necessity or a preference. What the long-term plan looks like. For a first episode with time to spare, an SSRI is a sensible starting point. For depression that has outlasted two solid antidepressant trials, or for a patient who cannot wait weeks, ketamine moves up the list.

Frequently Asked Questions

How fast does ketamine work compared to SSRIs?

Most patients notice a shift in mood, anxiety, or sleep within 24 to 72 hours of their first ketamine session. SSRIs typically take 4 to 6 weeks to reach full therapeutic effect. The mechanisms are different: ketamine drives a rapid burst of glutamate signaling, BDNF release, and synaptic regrowth, while SSRIs produce gradual brain adaptation to higher serotonin availability over weeks.

Can I take ketamine and an SSRI at the same time?

Yes, in most cases. SSRIs and SNRIs do not block ketamine's antidepressant effect, so patients are usually instructed to continue their current antidepressant during a ketamine course. The notable exceptions are benzodiazepines (Xanax, Klonopin, Ativan), which blunt ketamine's effect and should be held on session day, and lamotrigine (Lamictal), which can also reduce response. Discuss your full medication list with your prescribing physician before starting.

Will I have to stop my current antidepressant before starting ketamine?

Almost never. Most patients continue their SSRI or SNRI throughout ketamine treatment, since stopping abruptly can cause discontinuation symptoms and is rarely clinically necessary. If a future medication change makes sense, your physician will plan a gradual taper coordinated with your original prescriber, not a sudden swap.

Is ketamine a replacement for SSRIs or an addition to them?

It depends on your situation. For patients who have responded poorly to multiple SSRIs and SNRIs, ketamine often becomes the primary treatment with the antidepressant tapered off later. For patients who get partial relief from an SSRI but want more, ketamine is added on top to deepen response. For patients who have never tried an antidepressant, SSRIs are usually still the first-line treatment because of their longer track record and lower cost.

What response rate does ketamine have for treatment-resistant depression?

Meta-analyses of ketamine for treatment-resistant depression consistently report response rates (defined as a 50 percent or greater reduction in depression symptom scores) in the 60 to 75 percent range within 24 to 72 hours of a single dose. Full remission rates are lower, in the 30 to 50 percent range, and a complete induction course of 10 or more sessions tends to produce more durable benefit than a single session.

Are ketamine side effects worse than SSRI side effects?

They are different in profile. Ketamine produces short-term dissociation, mild blood pressure increase, and occasional nausea during sessions, with effects that fully resolve within hours. SSRIs produce sexual dysfunction, weight changes, sleep disruption, and emotional flattening that often persist as long as the medication is taken. Most patients tolerate both classes well; the trade-offs depend on which side-effect profile fits your life better.

When should someone switch from SSRIs to ketamine?

The most common moment is after two or more adequate antidepressant trials (each at therapeutic dose for 6 to 8 weeks) have failed to produce meaningful improvement. That clinical picture is treatment-resistant depression, and it is exactly the population for which ketamine has the strongest evidence. Other reasonable triggers: severe depression where waiting six weeks for an SSRI to maybe work is not safe, or patients whose SSRI side effects are intolerable.

How Discreet Ketamine Approaches This

Discreet Ketamine offers supervised at-home ketamine therapy for residents of Florida and New Jersey. Every patient is evaluated and treated personally by Dr. Ben Soffer, a board-certified physician. Treatment uses oral tablets and lozenges taken under clinical guidance, with dosing, monitoring, and follow-up built in. Supervised at-home programs start at $250 for a one-month plan, which sits below typical in-clinic infusion pricing.

"Dr. Ben has been extremely professional and has given exceptional care to me. Very fast scheduling appointment and seeing me, always answers my questions and emails (and I sent a bunch lol) and very empathetic and nice. I highly recommend and he uses a very efficient local pharmacy also. Thank you Dr Ben!"

Frank Macri, verified patient (Google review)

Ready to Start?

If traditional antidepressants have not provided the relief you need, ketamine therapy may offer a different path forward. Find out if you are a candidate. For a comparison against the other major non-medication option for treatment-resistant depression, see ketamine vs. TMS for treatment-resistant depression.

Check Your Eligibility →

Discreet Ketamine provides at-home ketamine therapy supervised by Dr. Ben Soffer, a board-certified physician, to residents of Florida and New Jersey.

References

1. Berman RM, et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 2000. PubMed
2. Zarate CA, et al. A randomized trial of an NMDA antagonist in treatment-resistant major depression. Archives of General Psychiatry, 2006. PubMed
3. Murrough JW, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. American Journal of Psychiatry, 2013. PubMed
4. Daly EJ, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression. JAMA Psychiatry, 2018. PubMed
5. Wilkinson ST, et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and meta-analysis. American Journal of Psychiatry, 2018. PubMed
6. U.S. Food and Drug Administration. FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic (2019). FDA.gov